These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 3290540)

  • 21. Acquired von Willebrand's syndrome associated with decrease of plasminogen activator and its inhibitor during hypothyroidism.
    Levesque H; Borg JY; Cailleux N; Vasse M; Daliphard S; Gancel A; Monconduit M; Courtois H
    Eur J Med; 1993 May; 2(5):287-8. PubMed ID: 8252160
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Acquired von Willebrand disease: potential contribution of the von Willebrand factor collagen-binding to the identification of functionally inhibiting auto-antibodies to von Willebrand factor: a rebuttal.
    Guerin V; Ryman A; Velez F
    J Thromb Haemost; 2008 Jun; 6(6):1051-2. PubMed ID: 18384652
    [No Abstract]   [Full Text] [Related]  

  • 23. Association of acquired von Willebrand syndrome with AL amyloidosis.
    Kos CA; Ward JE; Malek K; Sanchorawala V; Wright DG; O'Hara C; Connors L; Skinner M; Seldin DC
    Am J Hematol; 2007 May; 82(5):363-7. PubMed ID: 17205535
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antiphospholipid antibodies, haemostatic variables and thrombosis--a survey of 144 patients.
    Ames PR; Pyke S; Iannaccone L; Brancaccio V
    Thromb Haemost; 1995 May; 73(5):768-73. PubMed ID: 7482401
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [The pathogenesis of acquired von Willebrand's disease in a patient with asymptomatic monoclonal gammopathy; malignant lymphoma developing 30 months after onset of bruising].
    Takai Y; Hayasi H; Tsurumi N; Tsuda T; Fujlta T; Ohnoshi T; Kimura I
    Rinsho Ketsueki; 1987 Jan; 28(1):53-64. PubMed ID: 3494863
    [No Abstract]   [Full Text] [Related]  

  • 26. [Report of 2 cases with acquired von Willebrand disease and one with acquired hemophilia A].
    Martínez-Murillo C; Quintana González S; Ambriz Fernández R; Domínguez García V; Rodríguez Moyado H; Arias Aranda A; Collazo Jaloma J; Gutiérrez Romero M
    Rev Invest Clin; 1995; 47(3):211-6. PubMed ID: 7569365
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Acquired von Willebrand disease: potential contribution of the VWF:CB to the identification of functionally inhibiting auto-antibodies to von Willebrand factor.
    Coleman R; Favaloro EJ; Soltani S; Keng TB
    J Thromb Haemost; 2006 Sep; 4(9):2085-8. PubMed ID: 16961622
    [No Abstract]   [Full Text] [Related]  

  • 28. Acquired and reversible von Willebrand disease with high shear stress aortic valve stenosis.
    Yoshida K; Tobe S; Kawata M; Yamaguchi M
    Ann Thorac Surg; 2006 Feb; 81(2):490-4. PubMed ID: 16427837
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmacokinetic studies with FVIII/von Willebrand factor concentrate can be a diagnostic tool to distinguish between subgroups of patients with acquired von Willebrand syndrome.
    Luboshitz J; Lubetsky A; Schliamser L; Kotler A; Tamarin I; Inbal A
    Thromb Haemost; 2001 May; 85(5):806-9. PubMed ID: 11372672
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Diagnosis and management of acquired von Willebrand syndrome.
    Federici AB; Mannucci PM
    Clin Adv Hematol Oncol; 2003 Mar; 1(3):169-75. PubMed ID: 16224398
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Acquired von Willebrand's syndrome: a single institution experience.
    Kumar S; Pruthi RK; Nichols WL
    Am J Hematol; 2003 Apr; 72(4):243-7. PubMed ID: 12666134
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Acquired von Willebrand syndrome].
    Sucker C; Stockschläder M; Zotz RB; Scharf RE
    Dtsch Med Wochenschr; 2004 Jul; 129(28-29):1581-5. PubMed ID: 15243910
    [No Abstract]   [Full Text] [Related]  

  • 33. Successful treatment with recombinant factor VIIa of therapy-resistant severe bleeding in a patient with acquired von Willebrand disease.
    Friederich PW; Wever PC; Briët E; Doorenbos CJ; Levi M
    Am J Hematol; 2001 Apr; 66(4):292-4. PubMed ID: 11279642
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Plasma von Willebrand factor antigen concentration in dogs with hypothyroidism.
    Panciera DL; Johnson GS
    J Am Vet Med Assoc; 1994 Dec; 205(11):1550-3. PubMed ID: 7730121
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Use of intravenous immunoglobulin in patients with acquired von Willebrand syndrome.
    Federici AB
    Hum Immunol; 2005 Apr; 66(4):422-30. PubMed ID: 15866707
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Mechanisms of functional change of von Willebrand factor].
    Ramos F; Batlle J; López Borrasca A
    Med Clin (Barc); 1989 Apr; 92(15):588-94. PubMed ID: 2666773
    [No Abstract]   [Full Text] [Related]  

  • 37. Acquired abnormalities of von Willebrand factor: facts to consider in patients with unexpected bleeding.
    Ruggeri ZM
    J Lab Clin Med; 1993 Mar; 121(3):377-9. PubMed ID: 8445284
    [No Abstract]   [Full Text] [Related]  

  • 38. Acquired von Willebrand syndrome after exchange of the HeartMate XVE to the HeartMate II ventricular assist device.
    Malehsa D; Meyer AL; Bara C; Strüber M
    Eur J Cardiothorac Surg; 2009 Jun; 35(6):1091-3. PubMed ID: 19303790
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Decreased clearance of von Willebrand factor in a patient with type 2B von Willebrand disease following development of immune thrombocytopenia.
    Wang ZJ; Onwuzurike N; Callaghan MU; Rajpurkar M; Chitlur M; Lusher JM
    Pediatr Blood Cancer; 2008 Sep; 51(3):416-8. PubMed ID: 18493997
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Acquired von Willebrand's disease in chronic lymphatic leukemia].
    Cold S
    Ugeskr Laeger; 1986 Apr; 148(18):1093-4. PubMed ID: 3487862
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.